Global Portable Oxygen Concentrators Industry: Key Statistics and Insights in 2025-2033
Summary:
- The global portable oxygen concentrators market size reached USD 1.9 Billion in 2024.
- The market is expected to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033.
- North America leads the market, accounting for the largest portable oxygen concentrators market share.
- Pulse flow dominates the technology segment, holding the largest market share.
- Chronic obstructive pulmonary disease (COPD) accounts for the largest market share in the portable oxygen concentrator industry.
- Ambulatory surgery centers represent the leading end-user segment.
- The main reason for the growing demand for portable oxygen concentrators is the rising number of people with respiratory diseases.
- The market for portable oxygen concentrators is being reshaped by technological advancements and a growing demand for home healthcare.
Industry Trends and Drivers:
- Growing prevalence of respiratory diseases:
Conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are becoming more common due to factors like air pollution, smoking, and aging populations. COPD alone affects millions globally, requiring continuous oxygen therapy for patients to maintain proper oxygen levels. The demand for portable oxygen concentrators is further driven by the increasing number of patients needing oxygen therapy outside of traditional hospital settings. As these conditions require long-term management, portable oxygen concentrators provide a practical solution for mobility while maintaining necessary oxygen levels. The convenience these devices offer, allowing patients to engage in daily activities without being confined to a stationary oxygen source, is a key factor contributing to their growing popularity.
- Technological advancements and innovation:
Manufacturers are focusing on developing smaller, lighter, and more efficient devices to meet the increasing demand for mobility and ease of use. Innovations like longer battery life, more efficient oxygen delivery systems, and noise reduction technology are making these devices more appealing to users. Additionally, many new models are equipped with smart features that allow for remote monitoring and connectivity with healthcare providers, enabling real-time tracking of oxygen levels and device performance. This not only enhances the patient experience but also improves compliance with prescribed therapy. Portable oxygen concentrators with wireless connectivity and app-based controls are particularly popular among tech-savvy patients and caregivers, who appreciate the convenience and functionality.
- Rising home healthcare demand:
With healthcare costs steadily rising, patients and healthcare systems alike are seeking more cost-effective solutions, making home-based care an attractive alternative. Portable oxygen concentrators allow patients with chronic respiratory conditions to receive continuous oxygen therapy in the comfort of their own homes, reducing the need for frequent hospital visits or extended stays. This trend is particularly prominent among elderly populations, who often prefer home care over institutionalized settings. The flexibility and independence that these devices provide are highly valued, as they allow patients to maintain a higher quality of life while managing their conditions. Furthermore, healthcare providers are recommending home-based treatments to reduce the burden on hospitals and clinics, which is driving the demand for portable oxygen concentrators as a crucial component of modern respiratory care.
Grab a sample PDF of this report: https://www.imarcgroup.com/portable-oxygen-concentrators-market/requestsample
Portable Oxygen Concentrators Market Report Segmentation:
By Technology:
- Continuous Flow
- Pulse Flow
Pulse flow exhibits a clear dominance in the market accredited to its lightweight design and efficient oxygen delivery, making it ideal for mobile and active patients.
By Application:
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Respiratory Distress Syndrome
- Sleep Apnea
- Others
Chronic obstructive pulmonary disease (COPD) holds the biggest market owing to the increasing prevalence of respiratory condition that requires continuous oxygen therapy for patient management.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the portable oxygen concentrators market on account of a well-developed healthcare infrastructure and high healthcare expenditure, facilitating greater access to advanced medical technologies.
Top Portable Oxygen Concentrators Market Leaders:
The portable oxygen concentrators market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- Caire Inc. (NGK Spark Plug Co. Ltd)
- Chart Industries Inc.
- Drive Devilbiss Healthcare Limited (Drive International LLC)
- Inogen Inc.
- Invacare Corporation
- Koninklijke Philips N.V
- Nidek Medical India Pvt Ltd
- O2 Concepts LLC
- Precision Medical Inc. (BioHorizons Inc.)
- Resmed Inc.
- Teijin Limited
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145